IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease.

It remains unknown what causes inflammatory bowel disease (IBD), including signaling networks perpetuating chronic gastrointestinal inflammation in Crohn's disease (CD) and ulcerative colitis (UC), in humans. According to an analysis of up to 500 patients with IBD and 100 controls, we report that key transcripts of the IL-7 receptor (IL-7R) pathway are accumulated in inflamed colon tissues of severe CD and UC patients not responding to either immunosuppressive/corticosteroid, anti-TNF, or anti-α4β7 therapies. High expression of both IL7R and IL-7R signaling signature in the colon before treatment is strongly associated with nonresponsiveness to anti-TNF therapy. While in mice IL-7 is known to play a role in systemic inflammation, we found that in humans IL-7 also controlled α4β7 integrin expression and imprinted gut-homing specificity on T cells. IL-7R blockade reduced human T cell homing to the gut and colonic inflammation in vivo in humanized mouse models, and altered effector T cells in colon explants from UC patients grown ex vivo. Our findings show that failure of current treatments for CD and UC is strongly associated with an overexpressed IL-7R signaling pathway and point to IL-7R as a relevant therapeutic target and potential biomarker to fill an unmet need in clinical IBD detection and treatment.

[1]  V. Nérrière-Daguin,et al.  IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates , 2018, Nature Communications.

[2]  C. Buskens,et al.  Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease , 2018, PloS one.

[3]  C. Strassburg,et al.  Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy , 2017, PLoS pathogens.

[4]  L. Peyrin-Biroulet,et al.  Crohn's disease , 2017, The Lancet.

[5]  R. Owens,et al.  Oncostatin M drives intestinal inflammation in mice and its abundance predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease , 2017, Nature Medicine.

[6]  N. McGovern,et al.  Human Innate Lymphoid Cell Subsets Possess Tissue‐Type Based Heterogeneity in Phenotype and Frequency , 2017, Immunity.

[7]  S. Steurer,et al.  A pathogenic role for T cell–derived IL-22BP in inflammatory bowel disease , 2016, Science.

[8]  P. Rutgeerts,et al.  Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC , 2016, Gut.

[9]  Olivia I. Koues,et al.  Distinct Gene Regulatory Pathways for Human Innate versus Adaptive Lymphoid Cells , 2016, Cell.

[10]  E. Kraynov,et al.  Receptor occupancy and blocking of STAT5 signaling by an anti‐IL‐7 receptor α antibody in cynomolgus monkeys , 2016, Cytometry. Part B, Clinical cytometry.

[11]  W. Zhai,et al.  Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis , 2016, Journal of Neuroimmune Pharmacology.

[12]  Åsa K. Björklund,et al.  The heterogeneity of human CD127+ innate lymphoid cells revealed by single-cell RNA sequencing , 2016, Nature Immunology.

[13]  Isabelle Cleynen,et al.  Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[14]  M. Mapelli,et al.  Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin , 2015, The Journal of allergy and clinical immunology.

[15]  Youdong Pan,et al.  Regulatory T-cell depletion in the gut caused by integrin β7 deficiency exacerbates DSS colitis by evoking aberrant innate immunity , 2015, Mucosal Immunology.

[16]  M. Neurath,et al.  Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo , 2015, Gut.

[17]  Wei Zhang,et al.  Interleukin-7 Produced by Intestinal Epithelial Cells in Response to Citrobacter rodentium Infection Plays a Major Role in Innate Immunity against This Pathogen , 2015, Infection and Immunity.

[18]  Graham M Lord,et al.  The unusual suspects—innate lymphoid cells as novel therapeutic targets in IBD , 2015, Nature Reviews Gastroenterology &Hepatology.

[19]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[20]  Timothy L. Tickle,et al.  Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. , 2014, The Journal of clinical investigation.

[21]  L. Vogelpoel,et al.  Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells , 2014, Mucosal Immunology.

[22]  H. Waldmann,et al.  Guiding Postablative Lymphocyte Reconstitution as a Route Toward Transplantation Tolerance , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  F. Jahnsen,et al.  The short form of TSLP is constitutively translated in human keratinocytes and has characteristics of an antimicrobial peptide , 2014, Mucosal Immunology.

[24]  Markus F. Neurath,et al.  Cytokines in inflammatory bowel disease , 2014, Nature Reviews Immunology.

[25]  S. Brouard,et al.  IL-7 receptor blockade following T cell depletion promotes long-term allograft survival. , 2014, The Journal of clinical investigation.

[26]  M. Lederman,et al.  Decreases in Colonic and Systemic Inflammation in Chronic HIV Infection after IL-7 Administration , 2014, PLoS pathogens.

[27]  H. Dooms.  Interleukin-7: Fuel for the autoimmune attack. , 2013, Journal of autoimmunity.

[28]  Kristin Stephens,et al.  Vedolizumab as induction and maintenance therapy for Crohn's disease. , 2013, The New England journal of medicine.

[29]  P. Rutgeerts,et al.  Vedolizumab as induction and maintenance therapy for ulcerative colitis. , 2013, The New England journal of medicine.

[30]  M. Lenarz,et al.  RORγt⁺ innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. , 2013, Immunity.

[31]  Mingyan Zhu,et al.  A Genome-Wide Screen of CREB Occupancy Identifies the RhoA Inhibitors Par6C and Rnd3 as Regulators of BDNF-Induced Synaptogenesis , 2013, PloS one.

[32]  T. Olsson,et al.  Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity , 2013, Proceedings of the National Academy of Sciences.

[33]  C. Buskens,et al.  Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues , 2013, Nature Immunology.

[34]  Tetsuya Nakamura,et al.  Bone marrow-mesenchymal stem cells are a major source of interleukin-7 and sustain colitis by forming the niche for colitogenic CD4 memory T cells , 2012, Gut.

[35]  W. Sandborn,et al.  Crohn's disease , 2012, The Lancet.

[36]  T. Macdonald,et al.  What's the next best cytokine target in IBD? , 2012, Inflammatory bowel diseases.

[37]  I. Ordás,et al.  Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations , 2012, Gut.

[38]  Graham M Lord,et al.  The Transcription Factor T-bet Regulates Intestinal Inflammation Mediated by Interleukin-7 Receptor+ Innate Lymphoid Cells , 2012, Immunity.

[39]  P. Treuting,et al.  Interleukin-7 receptor blockade suppresses adaptive and innate inflammatory responses in experimental colitis , 2012, Journal of Inflammation.

[40]  G. Blancho,et al.  Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti‐CD28 Monovalent Fab′ Antibody , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[41]  M. Lederman,et al.  IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa. , 2012, Blood.

[42]  F. Carrette,et al.  IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. , 2012, Seminars in immunology.

[43]  C. Loddenkemper,et al.  Interleukin-7 Links T Lymphocyte and Intestinal Epithelial Cell Homeostasis , 2012, PloS one.

[44]  Miles Parkes,et al.  Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. , 2011, The Journal of clinical investigation.

[45]  R. Xavier,et al.  Genetics and pathogenesis of inflammatory bowel disease , 2011, Nature.

[46]  T. Fry,et al.  Harnessing the biology of IL-7 for therapeutic application , 2011, Nature Reviews Immunology.

[47]  P. Rutgeerts,et al.  Gene Expression Profiling and Response Signatures Associated With Differential Responses to Infliximab Treatment in Ulcerative Colitis , 2011, The American Journal of Gastroenterology.

[48]  Tetsuya Nakamura,et al.  Upregulated IL-7 Receptor α Expression on Colitogenic Memory CD4+ T Cells May Participate in the Development and Persistence of Chronic Colitis , 2011, The Journal of Immunology.

[49]  Tariq Ahmad,et al.  Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 , 2011, Nature Genetics.

[50]  S. Vermeire,et al.  Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects. , 2010, Journal of Crohn's & colitis.

[51]  G. Willimsky,et al.  Commensal microflora and interferon‐γ promote steady‐state interleukin‐7 production in vivo , 2010, European journal of immunology.

[52]  L. Lopalco,et al.  The role of IL‐1β in reduced IL‐7 production by stromal and epithelial cells: a model for impaired T‐cell numbers in the gut during HIV‐1 infection , 2010, Journal of internal medicine.

[53]  S. Kang,et al.  Complementary roles of retinoic acid and TGF-β1 in coordinated expression of mucosal integrins by T cells , 2010, Mucosal Immunology.

[54]  F. Powrie,et al.  Innate lymphoid cells drive IL-23 dependent innate intestinal pathology , 2010, Nature.

[55]  Isabelle Cleynen,et al.  Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment , 2009, PloS one.

[56]  D. Rampton,et al.  DIFFERENTIAL REGULATION OF INTERLEUKIN-17 AND INTERFERON- PRODUCTION IN INFLAMMATORY BOWEL DISEASE , 2011 .

[57]  G Van Assche,et al.  Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis , 2009, Gut.

[58]  B. Assouline,et al.  Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques. , 2009, Blood.

[59]  W. Leonard,et al.  New insights into the regulation of T cells by γc family cytokines , 2009, Nature Reviews Immunology.

[60]  M. Maeurer,et al.  Expression analysis and functional activity of interleukin-7 splice variants , 2009, Genes and Immunity.

[61]  G. Corazza,et al.  DIFFERENTIAL REGULATION OF INTERLEUKIN-17 AND INTERFERON-GAMMA PRODUCTION IN INFLAMMATORY BOWEL DISEASE , 2009 .

[62]  D. Laplaud,et al.  Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis. , 2008, The Journal of clinical investigation.

[63]  N. Sakamoto,et al.  Systemic, but Not Intestinal, IL-7 Is Essential for the Persistence of Chronic Colitis1 , 2008, The Journal of Immunology.

[64]  Silke Schmidt,et al.  Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis , 2007, Nature Genetics.

[65]  K. Tsuchiya,et al.  IL-7 Is Essential for the Development and the Persistence of Chronic Colitis1 , 2007, The Journal of Immunology.

[66]  Stefan Wirtz,et al.  Chemically induced mouse models of intestinal inflammation , 2007, Nature Protocols.

[67]  R. Mazzucchelli,et al.  Interleukin-7 receptor expression: intelligent design , 2007, Nature Reviews Immunology.

[68]  W. Agace.  Tissue-tropic effector T cells: generation and targeting opportunities , 2006, Nature Reviews Immunology.

[69]  T. Gingeras,et al.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.

[70]  W. Selby,et al.  Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells , 2006, The Journal of experimental medicine.

[71]  T. Hirano,et al.  Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7–dependent homeostatic proliferation of CD4+ T cells , 2006, The Journal of experimental medicine.

[72]  D. Adams,et al.  Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease , 2006, Nature Reviews Immunology.

[73]  T. Hibi,et al.  IL-7 exacerbates chronic colitis with expansion of memory IL-7Rhigh CD4+ mucosal T cells in mice. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[74]  Richard G. Jenner,et al.  Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[75]  A. Fischer,et al.  Interleukin‐7 receptor α (IL‐7Rα) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients , 2005, Immunological reviews.

[76]  Si-young Song,et al.  Retinoic acid imprints gut-homing specificity on T cells. , 2004, Immunity.

[77]  T. Hibi,et al.  Mucosal T Cells Expressing High Levels of IL-7 Receptor Are Potential Targets for Treatment of Chronic Colitis 1 , 2003, The Journal of Immunology.

[78]  Heinz Baumann,et al.  Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin , 2000, Nature Immunology.

[79]  J. Imanishi.  Expression of cytokines in bacterial and viral infections and their biochemical aspects. , 2000, Journal of biochemistry.

[80]  T. Hibi,et al.  Interleukin 7 Transgenic Mice Develop Chronic Colitis with Decreased Interleukin 7 Protein Accumulation in the Colonic Mucosa , 1998, The Journal of experimental medicine.

[81]  C. FordAlexander,et al.  ULCERATIVE colitis. , 1997, Journal of the American Medical Association.

[82]  H. Ishii,et al.  Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. , 1995, The Journal of clinical investigation.

[83]  C. Fiocchi,et al.  Immunopathogenesis of IBD: current state of the art , 2016, Nature Reviews Gastroenterology &Hepatology.

[84]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[85]  O. Dewit,et al.  Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study. , 2007, Acta gastro-enterologica Belgica.

[86]  G PLACITELLI,et al.  [Ulcerative colitis]. , 1958, La Riforma medica.